Marinus Pharmaceuticals Inc (MRNS)
1.42
-0.14
(-8.97%)
USD |
NASDAQ |
May 08, 16:00
1.44
+0.02
(+1.41%)
After-Hours: 20:00
Marinus Pharmaceuticals Free Cash Flow: -118.12M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -118.12M |
| September 30, 2023 | -113.10M |
| June 30, 2023 | -118.75M |
| March 31, 2023 | -128.40M |
| December 31, 2022 | -114.66M |
| September 30, 2022 | -115.12M |
| June 30, 2022 | -79.69M |
| March 31, 2022 | -69.50M |
| December 31, 2021 | -58.37M |
| September 30, 2021 | -52.29M |
| June 30, 2021 | -71.29M |
| March 31, 2021 | -63.48M |
| December 31, 2020 | -60.91M |
| September 30, 2020 | -60.79M |
| June 30, 2020 | -58.34M |
| March 31, 2020 | -51.26M |
| December 31, 2019 | -49.02M |
| September 30, 2019 | -41.98M |
| June 30, 2019 | -36.77M |
| March 31, 2019 | -33.56M |
| December 31, 2018 | -27.92M |
| Date | Value |
|---|---|
| September 30, 2018 | -23.43M |
| June 30, 2018 | -19.80M |
| March 31, 2018 | -18.45M |
| December 31, 2017 | -19.27M |
| September 30, 2017 | -20.58M |
| June 30, 2017 | -24.10M |
| March 31, 2017 | -26.25M |
| December 31, 2016 | -25.41M |
| September 30, 2016 | -24.41M |
| June 30, 2016 | -23.62M |
| March 31, 2016 | -22.66M |
| December 31, 2015 | -20.48M |
| September 30, 2015 | -17.40M |
| June 30, 2015 | -14.60M |
| March 31, 2015 | -11.42M |
| December 31, 2014 | -8.589M |
| September 30, 2014 | -9.750M |
| June 30, 2014 | -7.847M |
| March 31, 2014 | -7.067M |
| December 31, 2013 | -6.645M |
Free Cash Flow Range, Past 5 Years
-128.40M
Minimum
Mar 2023
-36.77M
Maximum
Jun 2019
-76.94M
Average
-63.48M
Median
Mar 2021
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals Inc | -4.272M |
| Soligenix Inc | -8.604M |
| Actinium Pharmaceuticals Inc | -39.72M |
| Macrogenics Inc | -79.97M |
| ADMA Biologics Inc | 3.819M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -26.99M |
| Cash from Investing (Quarterly) | 6.466M |
| Cash from Financing (Quarterly) | 0.661M |
| Free Cash Flow Per Share (Quarterly) | -0.4765 |
| Free Cash Flow to Equity (Quarterly) | -27.52M |
| Free Cash Flow to Firm (Quarterly) | -24.48M |
| Free Cash Flow Yield | -154.8% |